Actinine
Based on 1 Customer Validation
Actinine is a metabolic and pro-atherogenic intermediate with oral activity. Actinine acts as a substrate for the yeaW/X microbial enzyme complex to generate trimethylamine (TMA). Actinine accelerates atherosclerosis development in a gut microbe-dependent manner. Actinine can be used for the research of atherosclerosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.90%
- CAS 番号: 407-64-7
- 分子式: C7H15NO2
- 分子量:145.20
-
保管条件:
-20°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Endogenous Metabolite アイソフォーム固有の製品をすべて表示
More
生物活性
Actinine (γBB) served as a substrate for the microbial enzyme complex yeaW/X from E. coli, which exhibited TMA lyase activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chronic dietary supplementation with γBB (1.3% gm/gm; dietary supplementation; from weaning until 10 weeks of age) induces gut microbial functional capacity to produce TMA and TMAO from γBB but not from L-carnitine[1].
Gut microbial colonization is required for γBB (gastric gavage) conversion to TMA and TMAO, while γBB conversion to carnitine occurs via the host endogenous pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J, Apoe−/− (female)[1]
-
Dosage:1.3% (gm/gm, dietary supplementation)
-
Administration:dietary supplementation; from weaning until 19 weeks of age
-
Result:Increased total aortic root plaque area by 50% compared to chow-fed controls; Eliminated plaque area increase when gut microbes were suppressed by antibiotics.
-
Animal Model:C57BL/6J, Apoe−/− (female)[1]
-
Dosage:1.3% (gm/gm, dietary supplementation)
-
Administration:dietary supplementation; from weaning until 10 weeks of age; gastric gavage (d9-γBB or d3-carnitine challenge)
-
Result:Markedly increased production of d9-TMA and d9-TMAO from d9-γBB challenge compared to chow-fed controls; Modestly increased d3-TMA and d3-γBB production from d3-carnitine challenge; Showed no enhanced d3-TMAO production from d3-carnitine challenge.
-
Animal Model:Swiss Webster (female, germ-free)[1]
-
Dosage:Not specified
-
Administration:gastric gavage
-
Result:Produced no detectable d9-TMA or d9-TMAO from d9-γBB challenge; Produced d9-carnitine from d9-γBB challenge; Acquired capacity to produce d9-TMA and d9-TMAO from d9-γBB challenge after conventionalization.
化学情報
-
CAS 番号 407-64-7
-
性状 Solid
-
分子量 145.20
-
分子式 C7H15NO2
-
Color White to off-white
-
SMILES
C[N+](C)(C)CCCC([O-])=O
-
別名
γ-Butyrobetaine; Deoxycarnitine
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
溶剤 & 溶解度
H2O : ≥ 100 mg/mL (688.71 mM)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. HY-113270.pdf
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 6.8871 mL | 34.4353 mL | 68.8705 mL | 172.1763 mL |
| 5 mM | 1.3774 mL | 6.8871 mL | 13.7741 mL | 34.4353 mL | |
| 10 mM | 0.6887 mL | 3.4435 mL | 6.8871 mL | 17.2176 mL | |
| 15 mM | 0.4591 mL | 2.2957 mL | 4.5914 mL | 11.4784 mL | |
| 20 mM | 0.3444 mL | 1.7218 mL | 3.4435 mL | 8.6088 mL | |
| 25 mM | 0.2755 mL | 1.3774 mL | 2.7548 mL | 6.8871 mL | |
| 30 mM | 0.2296 mL | 1.1478 mL | 2.2957 mL | 5.7392 mL | |
| 40 mM | 0.1722 mL | 0.8609 mL | 1.7218 mL | 4.3044 mL | |
| 50 mM | 0.1377 mL | 0.6887 mL | 1.3774 mL | 3.4435 mL | |
| 60 mM | 0.1148 mL | 0.5739 mL | 1.1478 mL | 2.8696 mL | |
| 80 mM | 0.0861 mL | 0.4304 mL | 0.8609 mL | 2.1522 mL | |
| 100 mM | 0.0689 mL | 0.3444 mL | 0.6887 mL | 1.7218 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Actinine 関連分類
HY-113270 関連分類
Powered by Bioz
- Actinine
- 407-64-7
- γ-Butyrobetaine
- Deoxycarnitine
- Endogenous Metabolite
- E. coli
- atherosclerosis
- trimethylamine-N-oxide (TMAO)
- L-carnitine
- trimethylamine (TMA)
- host hepatic
- host endogenous carnitine biosynthesis pathway
- gut microbial communities
- yeaW/X microbial enzyme complex
- flavin monooxygenase 3 (FMO3)
- Inhibitor
- inhibitor
- inhibit